Item 2.02 Results of Operations and Financial Condition.
On
Item 7.01 Regulation FD Disclosure.
Included as Exhibit 99.2 to this Current Report on Form 8-K is a presentation
titled "Building a vibrant enterprise to deliver transformational medicines,"
dated
The information in this Current Report on Form 8-K, including Exhibit 99.1 and Exhibit 99.2, shall not be deemed "filed" for purposes of Section 18 of the Securities Exchange Act of 1934, as amended (the "Exchange Act") or otherwise subject to the liabilities of that section, nor shall it be deemed incorporated by reference in any filing under the Securities Act of 1933, as amended, or the Exchange Act, except as expressly set forth by specific reference in such a filing.
Item 9.01 Financial Statements and Exhibits. (d) Exhibits.
99.1 Excerpt of Conference Call Transcript
99.2 Presentation titled "Building a vibrant enterprise to deliver
transformational medicines," dated
104 Cover Page Interactive Data File (embedded within the Inline XBRL document)
--------------------------------------------------------------------------------
© Edgar Online, source